We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-15.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$138M
AUM Growth
-$54.6M
Cap. Flow
-$14.6M
Cap. Flow %
-10.54%
Top 10 Hldgs %
60.84%
Holding
122
New
13
Increased
15
Reduced
28
Closed
30

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.49M
2
ADTN icon
Adtran
ADTN
+$2.33M
3
VIR icon
Vir Biotechnology
VIR
+$2.27M
4
SSYS icon
Stratasys
SSYS
+$1.84M
5
PUBM icon
PubMatic
PUBM
+$1.47M

Top Sells

Rank Stock Value
1
TRIL
Trillium Therapeutics Inc.
TRIL
+$8.18M
2
AFRM icon
Affirm
AFRM
+$2.92M
3
UPST icon
Upstart Holdings
UPST
+$2.87M
4
NUAN
Nuance Communications, Inc.
NUAN
+$2.06M
5
ATRA icon
Atara Biotherapeutics
ATRA
+$1.81M

Sector Composition

Rank Sector Weight
1 Healthcare 81.55%
2 Technology 7%
3 Communication Services 4.59%
4 Consumer Discretionary 2.09%
5 Energy 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DKNG icon
101
DraftKings
DKNG
$10.8B
– –
-9,600
Closed -$462K
F icon
102
Ford
F
$56.3B
– –
-20,000
Closed -$283K
GAMB
103
DELISTED
Gambling.com
GAMB
– –
-30,000
Closed -$274K
JMIA
104
Jumia Technologies
JMIA
$727M
– –
-14,200
Closed -$264K
KALA icon
105
KALA BIO
KALA
$13.6M
– –
-76
Closed -$498K
KPLT icon
106
Katapult Holdings
KPLT
$30.2M
– –
-7,000
Closed -$950K
KPTI icon
107
Karyopharm Therapeutics
KPTI
$43.3M
– –
-933
Closed -$81K
QDEL icon
108
QuidelOrtho
QDEL
$1.19B
– –
-1,000
Closed -$141K
SLV icon
109
iShares Silver Trust
SLV
$29.9B
– –
-36,000
Closed -$739K
U icon
110
Unity
U
$15.5B
– –
-2,000
Closed -$253K
ZYME icon
111
Zymeworks
ZYME
$1.73B
– –
-14,000
Closed -$407K
TECX
112
Tectonic Therapeutic
TECX
$558M
– –
-250
Closed -$17K
PHXM
113
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
– –
-200
Closed -$12K
EGLX
114
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
– –
-40,000
Closed -$145K
RETA
115
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-6,000
Closed -$604K
COUP
116
DELISTED
Coupa Software Incorporated
COUP
– –
-2,400
Closed -$526K
AGTC
117
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-20,000
Closed -$60K
ZVO
118
DELISTED
Zovio Inc. Common Stock
ZVO
– –
-30,000
Closed -$72K
NUAN
119
DELISTED
Nuance Communications, Inc.
NUAN
– –
-37,500
Closed -$2.06M
TRIL
120
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-466,000
Closed -$8.18M
XEC
121
DELISTED
CIMAREX ENERGY CO
XEC
– –
-10,000
Closed -$872K
BLPH
122
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
– –
-25,000
Closed -$102K
1 2 3 4
5

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, ACT Capital Management held 122 positions worth $138M, down 28% from $193M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

ACT Capital Management withdrew a net $14.6M in Q4 2021, closing 30 positions and reducing 28 holdings. Its most notable exit was Trillium Therapeutics Inc., an estimated $8.18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 79% a quarter earlier, followed by Technology and Communication Services.

Against the trend, ACT Capital Management opened a new position in Meta Platforms (Facebook) worth $2.52M.

  • ACT Capital Management's largest Q4 2021 buy was Meta Platforms (Facebook): 7,500 shares worth $2.52M.
  • ACT Capital Management added most to Stratasys in Q4 2021, an estimated $1.84M increase.
  • ACT Capital Management's biggest Q4 2021 reduction was Upstart Holdings, cutting an estimated $2.87M.
  • ACT Capital Management fully exited Trillium Therapeutics Inc. in Q4 2021, selling an estimated $8.18M.
  • ACT Capital Management's ten largest holdings make up 61% of its $138M portfolio in Q4 2021.
  • ACT Capital Management opened 13 new positions and closed 30 in Q4 2021.
  • ACT Capital Management's portfolio value fell 28% quarter-over-quarter to $138M.

Based on ACT Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.